Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Подход к выбору противоастматической терапии
Подход к выбору противоастматической терапии
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Asthma. Quick asthma facts and The Faces of asthma. Geneva: World Health Organization, 2010. Available from: http://www.who.int/respiratory/asthma/en/
2. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma controlbeing achieved ? A hypotesis-generating study. Eur Respir J 2001; 17: 589–95.
3. Белевский А.С. Взгляд на пациента с точки зрения пациента: исследование INSPIRE. Cons. Med. Т. 9. 3 (207). http://old.consilium-medicum.com/media/consilium/ 07_03/40.shtml
4. Черняк Б.А., Воржева И.И. Агонисты β2-адренергических рецепторов в терапии бронхиальной астмы: вопросы эффективности и безопасности. Сons. Med. 2006; 8 (10).
5. National Institutes of Health, National Heart, Lung and Blood Institute. Global Initiative for asthma: pocket Guide for Asthma Management and Prevention. NHLBI/WHO NIH; 1998. Publication No96-36558B.
6. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–6.
7. Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6.
8. Drazen JM, Israel E, Boushey HA et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996; 335: 841–7.
9. Pearlman DS, Chervinsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420–5.
10. Kesten S, Chapman KR, Broder I et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622–5.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219–24.
12. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ et al. Effects of 22 months of treatment with inhaled cor-ticosteroids and/or beta-2-agonists on lung function, airway responsive-ness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547–54.
13. Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, D.C.: National Heart, Lung, and Blood Institute, 1995. Publication №95-3659.
14. Nora YK Chew, Hak-Kim Chan. In vitro aerosol performance and dose uniformity between the Foradile aerolizer and the Oxis Turbuhaler. J Aerosol Med 2001; 14 (4): 495–501.
2. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma controlbeing achieved ? A hypotesis-generating study. Eur Respir J 2001; 17: 589–95.
3. Белевский А.С. Взгляд на пациента с точки зрения пациента: исследование INSPIRE. Cons. Med. Т. 9. 3 (207). http://old.consilium-medicum.com/media/consilium/ 07_03/40.shtml
4. Черняк Б.А., Воржева И.И. Агонисты β2-адренергических рецепторов в терапии бронхиальной астмы: вопросы эффективности и безопасности. Сons. Med. 2006; 8 (10).
5. National Institutes of Health, National Heart, Lung and Blood Institute. Global Initiative for asthma: pocket Guide for Asthma Management and Prevention. NHLBI/WHO NIH; 1998. Publication No96-36558B.
6. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–6.
7. Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6.
8. Drazen JM, Israel E, Boushey HA et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996; 335: 841–7.
9. Pearlman DS, Chervinsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420–5.
10. Kesten S, Chapman KR, Broder I et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622–5.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219–24.
12. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ et al. Effects of 22 months of treatment with inhaled cor-ticosteroids and/or beta-2-agonists on lung function, airway responsive-ness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 146: 547–54.
13. Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, D.C.: National Heart, Lung, and Blood Institute, 1995. Publication №95-3659.
14. Nora YK Chew, Hak-Kim Chan. In vitro aerosol performance and dose uniformity between the Foradile aerolizer and the Oxis Turbuhaler. J Aerosol Med 2001; 14 (4): 495–501.
Авторы
Е.В.Назарова, Е.А.Латышева, К.С.Павлова, О.М.Курбачева, Н.И.Ильина
ФГБУ ГНЦ Институт иммунологии ФМБА России, Москва
ФГБУ ГНЦ Институт иммунологии ФМБА России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.